MedAvail Holdings, Inc.
MDVL · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $43,109 | $22,129 | $13,968 | $3,771 |
| % Growth | 94.8% | 58.4% | 270.4% | – |
| Cost of Goods Sold | $40,524 | $21,812 | $8,805 | $2,823 |
| Gross Profit | $2,585 | $317 | $5,163 | $948 |
| % Margin | 6% | 1.4% | 37% | 25.1% |
| R&D Expenses | $1,115 | $849 | $682 | $1,106 |
| G&A Expenses | $23,499 | $22,277 | $16,562 | $15,524 |
| SG&A Expenses | $31,985 | $29,481 | $19,605 | $18,800 |
| Sales & Mktg Exp. | $8,486 | $7,204 | $3,043 | $3,276 |
| Other Operating Expenses | $15,907 | $13,496 | $5,687 | $1,749 |
| Operating Expenses | $49,007 | $43,826 | $25,974 | $21,655 |
| Operating Income | -$46,422 | -$43,509 | -$20,811 | -$20,707 |
| % Margin | -107.7% | -196.6% | -149% | -549.1% |
| Other Income/Exp. Net | -$1,170 | -$304 | -$5,999 | -$826 |
| Pre-Tax Income | -$47,592 | -$43,813 | -$26,810 | -$21,533 |
| Tax Expense | $24 | $2 | -$674 | $734 |
| Net Income | -$47,616 | -$43,815 | -$26,136 | -$22,267 |
| % Margin | -110.5% | -198% | -187.1% | -590.5% |
| EPS | -36.2 | -67.08 | -228.38 | -691.31 |
| % Growth | 46% | 70.6% | 67% | – |
| EPS Diluted | -36.2 | -67.08 | -228.38 | -691.29 |
| Weighted Avg Shares Out | 1,316 | 653 | 114 | 32 |
| Weighted Avg Shares Out Dil | 1,316 | 653 | 114 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $79 | $43 | $45 |
| Interest Expense | $1,172 | $589 | $1,241 | $734 |
| Depreciation & Amortization | $2 | $285 | -$67 | $1,687 |
| EBITDA | -$46,418 | -$42,939 | -$19,006 | -$19,020 |
| % Margin | -107.7% | -194% | -136.1% | -504.4% |